Piezo1 limits the potential of regulatory T cells (Treg) to mitigate autoimmune neuroinflammation. Inhibiting Piezo1 could lead to new treatments for autoimmune disorders like multiple sclerosis.
Organ-on-a-chip models reveal how different tissue contribute to inflammatory diseases such as ulcerative colitis.
